Sectors
ROIV
Roivant Sciences Ltd.
34.64
2 x 32.33
2 x 36.94
bid
ask
-
0.07
0.20%
2 @ 04:16 PM
35.55 +0.91 (2.63%)
| Ytd | 59.63% | |
| 1y | 190.36% |
34.02
day range
35.34
11.94
52 week range
37.97
| Open | 34.65 | Prev Close | 34.71 | Low | 34.02 | High | 35.34 | Mkt Cap | 25.02B |
| Vol | 39.07M | Avg Vol | 5.57M | EPS | -0.47 | P/E | N/A | Forward P/E | -20.17 |
| Beta | 1.13 | Short Ratio | 6.00 | Inst. Own | 78.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 35.08 | 200-d Avg | 28.14 | 1yr Est | 41.86 |
| Income Statement | |||
| Total Revenue | 1.44M | ||
| Revenues (USD) | 1.44M | ||
| Cost of Revenue | 284.00K | ||
| Gross Profit | 1.16M | ||
| Operating Expenses | 367.15M | ||
| Research and Development Expense | 202.02M | ||
| Selling, General and Administrative Expense | 165.53M | ||
| Operating Income | -365.99M | ||
| Income Tax Expense | -3.96M | ||
| Net Income | -189.84M | ||
| Net Income Common Stock | -189.84M | ||
| Net Income Common Stock (USD) | -189.84M | ||
| Consolidated Income | -290.61M | ||
| Net Income to Non-Controlling Interests | -100.77M | ||
| Earnings per Basic Share | -0.26 | ||
| Earnings per Basic Share (USD) | -0.26 | ||
| Earnings per Diluted Share | -0.26 | ||
| Earning Before Interest & Taxes (EBIT) | -193.79M | ||
| Earning Before Interest & Taxes (USD) | -193.79M | ||
| Weighted Average Shares | 720.78M | ||
| Weighted Average Shares Diluted | 720.78M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.25B | ||
| Cash and Equivalents (USD) | 1.25B | ||
| Investments | 3.04B | ||
| Investments Current | 2.59B | ||
| Investments Non-Current | 444.62M | ||
| Trade and Non-Trade Receivables | 771.63M | ||
| Current Assets | 4.74B | ||
| Property, Plant & Equipment Net | 90.21M | ||
| Total Assets | 5.31B | ||
| Debt Current | 12.38M | ||
| Total Debt | 107.15M | ||
| Current Liabilities | 283.60M | ||
| Debt Non-Current | 94.77M | ||
| Total Liabilities | 384.62M | ||
| Accumulated Retained Earnings (Deficit) | -900.35M | ||
| Accumulated Other Comprehensive Income | 701.00K | ||
| Shareholders Equity | 4.23B | ||
| Shareholders Equity (USD) | 4.23B | ||
| Assets Non-Current | 564.41M | ||
| Total Debt (USD) | 107.15M | ||
| Liabilities Non-Current | 101.02M | ||
| Trade and Non-Trade Payables | 25.08M | ||
| Tax Liabilities | 74.18M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.99M | ||
| Net Cash Flow from Financing | -181.51M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -170.44M | ||
| Capital Expenditure | -419.00K | ||
| Issuance (Purchase) of Equity Shares | -206.09M | ||
| Net Cash Flow from Investing | 281.26M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 281.68M | ||
| Net Cash Flow from Operations | -270.50M | ||
| Effect of Exchange Rate Changes on Cash | 315.00K | ||
| Share Based Compensation | 83.34M | ||